Early response to SPN-812 (viloxazine extended-release) can predict efficacy outcome in pediatric subjects with ADHD: a machine learning post-hoc analysis of four randomized clinical trials

Autor: Faraone, Stephen V., Gomeni, Roberto, Hull, Joseph T., Busse, Gregory D., Melyan, Zare, O'Neal, Welton, Rubin, Jonathan, Nasser, Azmi
Zdroj: In Psychiatry Research February 2021 296
Databáze: ScienceDirect